Showing results (131-140 of 1,842) with videos related to

Sort By:
Pageof 185
Journal of Managed Care & Specialty Pharmacy|September 25, 2018
Budget Impact Analysis of Eliglustat for the Treatment of Gaucher Disease Type 1 in the United StatesLuba Nalysnyk, Rebecca Sugarman, Clifford Cele, et al.
Journal of Managed Care & Specialty Pharmacy|June 1, 2018
The Effect of an Educational Intervention on Adherence to Intraocular Pressure-Lowering Medications in a Large Cohort of Older Adults with GlaucomaRichard Fiscella, Eleanor Caplan, Pravin Kamble, et al.
Journal of Managed Care & Specialty Pharmacy|March 27, 2018
Disparities in Initial Oral Antidiabetic Medication Adherence Among Veterans with Incident DiabetesJustin D Gatwood, Marie Chisholm-Burns, Robert Davis, et al.
Journal of Managed Care & Specialty Pharmacy|March 27, 2018
Michigan Pharmacists Transforming Care and Quality: Developing a Statewide Collaborative of Physician Organizations and Pharmacists to Improve Quality of Care and Reduce CostsHae Mi Choe, Alexandra Tungol Lin, Kathleen Kobernik, et al.
Journal of Managed Care & Specialty Pharmacy|February 4, 2020
Cost-Effectiveness Analysis of Adjuvant Neratinib Following Trastuzumab in Early-Stage HER2-Positive Breast CancerPhuong T Tran, Vakaramoko Diaby
Journal of Managed Care & Specialty Pharmacy|February 4, 2020
Projecting the Long-Term Economic Impact of Once-Monthly Paliperidone Palmitate Versus Oral Atypical Antipsychotics in Medicaid Patients with SchizophreniaAntoine C El Khoury, Dominic Pilon, Laura Morrison, et al.
Journal of Managed Care & Specialty Pharmacy|June 29, 2021
The effectiveness and value of bempedoic acid and inclisiran for heterozygous familial hypercholesterolemia and secondary prevention of ASCVDFoluso Agboola, Grace A Lin, Dhruv S Kazi, et al.
Journal of Managed Care & Specialty Pharmacy|June 29, 2021
The use of all-oral direct-acting antivirals in hepatitis C virus-infected patients with substance use disordersXinyi Jiang, Hyun Jin Song, Wei Wang, et al.
Pageof 185